Designed for developers of medicinal products and other similarly regulated technologies. Allows you to seek joint advice from the Medicines and Healthcare products Regulatory Agency (MHRA) and NICE Scientific Advice.
A 4 hourvirtual meeting with NICE, MHRA and a panel of experts.
- Single advice
reportwith a joint NICE and MHRA advice summary.
- Detailed exploration of health technology assessment and regulatory issues.
If you are an SME seeking joint advice from NICE and the MHRA, please contact us to discuss your options.
Once the project timeline has been provisionally agreed, we will share the latest version of the briefing book template and supporting guidance to help you in your preparations.Make an enquiryFrequently asked questions
We were pleasantly surprised by NICE’s collaborative approach and keenness to understand the project!
If you think you have left it too late to seek advice, contact us. We may still be able to help.
You contact us to discuss your requirements. You answer a series of preliminary questions about your product. We contact the MHRA and agree a timeline between the 3 parties.
You sign and return the contract
This must happen before the agreed submission date for the draft briefing book.
Send us your draft briefing book
This is the key document that the project is centred around. A briefing book template for pharmaceutical companies is available for you to use. Guidance notes are also available
We send you a quote
Based on the content of your draft briefing book, we send you an initial quote for the project. You then have an opportunity to make any changes to your final briefing book before submitting the final version.
Submit your final briefing book
We confirm the project fee
Once we've reviewed the final briefing book, we confirm the fee. This may differ from the initial quote, if any changes were made.
We send you an updated contract
We update the contract with the confirmed project fee and send you a copy for your records.
We may ask some clarification questions about your product development plans
Having identified and spoken to our panel of experts and the MHRA, we may ask you to clarify or provide further information on certain details in your briefing book.
You'll have approximately 2 weeks to respond.
We hold a virtual meeting with you, MHRA and a panel of experts
This will be a 4 hour exploratory open discussion of the issues we have identified in your briefing book. This helps us formulate our answers for the final advice report.
We send our advice reports
The final advice reports from NICE and the MHRA are combined into one overall report with a joint summary agreed by both parties.
Please allow a further 2 weeks if your project is classified as large.
Clarification stage (optional)
You can send us any clarification questions you have about the report
These questions are to clarify the meaning of the advice and cannot be requests for new information.
Further follow-up advice can be arranged for an additional fee. Please contact us to discuss any requirements.
We respond to your clarification questions, in writing